Literature DB >> 3808627

Progression of nonischemic central retinal vein obstruction to the ischemic variant.

J Minturn, G C Brown.   

Abstract

The cases of 310 patients with central retinal vein obstruction (CRVO) were reviewed. Included among these were 16 who presented with a nonischemic CRVO on fluorescein angiography that progressed to an ischemic CRVO. This subgroup was compared to a control group of 34 patients with a nonischemic CRVO that did not progress to the ischemic state with at least a one year follow-up. Among the eyes in the group that progressed, there was noted to be a higher incidence of initial visual acuity less than or equal to 6/30 (P = 0.005), severe macular edema (P = 0.021), and progressive intraretinal bleeding (P less than 0.0001) than in the control group. There was no significant difference between the groups in regard to age, sex, increased intraocular pressure, or systemic disease.

Entities:  

Mesh:

Year:  1986        PMID: 3808627     DOI: 10.1016/s0161-6420(86)33599-1

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

1.  The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary.

Authors:  S Sivaprasad; W M Amoaku; P Hykin
Journal:  Eye (Lond)       Date:  2015-08-28       Impact factor: 3.775

Review 2.  Central retinal vein occlusion: what's the story?

Authors:  T H Williamson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

3.  Induced chorioretinal venous anastomosis in experimental retinal branch vein occlusion.

Authors:  I L McAllister; D Y Yu; S Vijayasekaran; C Barry; I Constable
Journal:  Br J Ophthalmol       Date:  1992-10       Impact factor: 4.638

4.  Electroretinogram b/a wave ratio improvement in central retinal vein obstruction.

Authors:  Y Matsui; O Katsumi; H Sakaue; T Hirose
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

5.  Morphological and Functional Outcomes after Intravitreal Dexamethasone Injection for Macular Edema in Patients with Central Vein Occlusion at 48-Week Follow-Up.

Authors:  Cristina Nicula; Dorin Nicula; Anca Rednik; Adriana Bulboaca; Ovidiu Crișan
Journal:  J Ophthalmol       Date:  2020-02-11       Impact factor: 1.909

6.  Choroidal Vascularity Index in Central and Branch Retinal Vein Occlusion.

Authors:  Pasquale Loiudice; Giuseppe Covello; Michele Figus; Chiara Posarelli; Maria Sole Sartini; Giamberto Casini
Journal:  J Clin Med       Date:  2022-08-15       Impact factor: 4.964

7.  The Caliber of Optociliary Shunt Vessels Is Associated with Macular Blood Flow and Visual Acuity in Central Retinal Vein Occlusion.

Authors:  Masanori Kanai; Susumu Sakimoto; Chikako Hara; Yoko Fukushima; Kaori Sayanagi; Kentaro Nishida; Hirokazu Sakaguchi; Kohji Nishida
Journal:  Ophthalmol Sci       Date:  2021-11-20

8.  Real-Life Efficacy of Bevacizumab Treatment for Macular Edema Secondary to Central Retinal Vein Occlusion according to Pro Re Nata or Treat-and-Extend Regimen in Eyes with or without Epiretinal Membrane.

Authors:  Moustafa Hamam; Neil Lagali; Elie Abdulnour; Helen Setterud; Björn Johansson; Pierfrancesco Mirabelli
Journal:  J Ophthalmol       Date:  2022-10-03       Impact factor: 1.974

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.